Quality Site Head
CRISPR Therapeutics
Summary
Reporting to the Vice President, Head of Quality, the Quality Site Head will play a key leadership role both at CRISPR's internal manufacturing site and within the Quality Assurance function as a whole. The ideal candidate will lead by example to promote excellence in every aspect of internal manufacturing operations as part of CRISPR's mission to develop impactful therapies at the forefront of gene-editing technology.
Job description
Position Summary
Reporting to the Vice President, Head of Quality, the Quality Site Head will play a key leadership role both at CRISPR's internal manufacturing site and within the Quality Assurance function as a whole. The ideal candidate will lead by example to promote excellence in every aspect of internal manufacturing operations as part of CRISPR's mission to develop impactful therapies at the forefront of gene-editing technology.
Responsibilities
- Foster a Quality culture that values innovation, continuous improvement, and personal accountability
- Provide strategic direction and operational leadership for the site Quality function at CRISPR's internal manufacturing facility
- Responsible for end-to-end Quality within the site, including FUSE qualification/validation, materials management, batch record reviews, change control, and exceptions
- Responsible for Product Disposition ensuring that intermediates and drug products are manufactured and tested in accordance with GMP and regulatory submissions
- Establish quality metrics to demonstrate adherence to GMP regulations and CRISPR procedures
- Collaborate with internal partners to enable compliant and successful manufacturing (e.g. technology transfers, validation, testing, and lifecycle management)
- Lead and maintain site inspection readiness, and host audits and Health Authority inspections
- Work closely with Quality Systems and Compliance and External Quality Operations to advance all aspects of CRISPR's GMP Quality processes
- Provide leadership and management support for activities to drive a fast paced, highly efficient learning culture
- Be a champion of a highly collaborative, transparent, data driven, make it happen' culture
Minimum Qualifications
- BS/MS in relevant scientific discipline and 15-20+ years of experience in a biopharmaceutical organization; including direct experience in Quality Assurance at a GMP manufacturing facility
- Expertise in FDA/EMA/ICH regulations and guidelines and a strong understanding of pharmaceutical product development lifecycle are required
- Able to simultaneously operate at both a strategic and hands-on level in a GMP environment
- Inclusive leadership skills and keen organizational awareness, enabling the development of strong working relationships with colleagues regardless of job level or function
- Ability to navigate a constantly evolving scientific and regulatory environment, and approach challenges with a proactive, ownership mindset
- Direct experience hosting Health Authority inspections
- Demonstrated ability to mentor staff and build an effective Quality team
- Self-awareness, integrity, judgment, and ability to remain calm and consistent under pressure
- Role model for Quality mindset, as well as the CRISPR CUREs values (Collaboration, Undaunted, Results Oriented, Entrepreneurial)
- Ability to execute and follow-through to completion
- Strong leadership and an innate ability to collaborate and build relationships is critical
Preferred Qualifications
- Prior experience in the manufacture of cell and gene therapy products
- Progressive Quality Control and/or Analytical Sciences experience, including method transfer, validation and routine release and stability testing operations
- Advanced degree such as PhD in Life Sciences or a related field
Competencies
- Collaborative – Openness, One Team
- Undaunted – Fearless, Can-do attitude
- Results Orientation – Delivering progress toward our mission. Sense of urgency in solving problems.
- Entrepreneurial Spirit – Proactive. Ownership mindset.
Requirements
- BS/MS in relevant scientific discipline
- 15-20+ years of experience in a biopharmaceutical organization
- Direct experience in Quality Assurance at a GMP manufacturing facility
- Expertise in FDA/EMA/ICH regulations and guidelines
- Strong understanding of pharmaceutical product development lifecycle
- Able to simultaneously operate at both a strategic and hands-on level in a GMP environment
- Inclusive leadership skills and keen organizational awareness
- Ability to navigate a constantly evolving scientific and regulatory environment
- Direct experience hosting Health Authority inspections
- Demonstrated ability to mentor staff and build an effective Quality team
- Self-awareness, integrity, judgment, and ability to remain calm and consistent under pressure
- Ability to execute and follow-through to completion
- Strong leadership and an innate ability to collaborate and build relationships
Benefits
- Bonus
- Equity
- Health Insurance
Company overview
CRISPR Therapeutics AG is a pioneering Swiss-American biotechnology company founded in 2013 that specializes in developing transformative gene-based medicines using the revolutionary CRISPR/Cas9 gene editing platform. Headquartered in Zug, Switzerland with major R&D operations in Boston, Massachusetts and San Francisco, California, the company was co-founded by Nobel Prize winner Emmanuelle Charpentier and represents one of the first commercial entities to harness CRISPR technology for therapeutic applications. CRISPR Therapeutics achieved a historic milestone in December 2023 with the FDA approval of CASGEVY® (exagamglogene autotemcel), the world's first CRISPR-based therapy for treating sickle cell disease and transfusion-dependent beta thalassemia. The company maintains a diverse pipeline targeting hemoglobinopathies, oncology, regenerative medicine, cardiovascular diseases, autoimmune disorders, and rare genetic conditions. Through strategic partnerships with industry leaders like Vertex Pharmaceuticals and Bayer, CRISPR Therapeutics continues to advance its innovative platform, employing approximately 400 professionals globally and maintaining a strong financial position with over $1.8 billion in cash and marketable securities as of 2025.